{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T09:53:13Z","timestamp":1793181193062,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejps.2024.106723","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T04:17:54Z","timestamp":1707279474000},"page":"106723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Safety, tolerability, pharmacokinetics and neutrophil elastase inhibitory effects of Sivelestat: A randomized, double-blind, placebo-controlled single- and multiple-dose escalation study in Chinese healthy subjects"],"prefix":"10.1016","volume":"195","author":[{"given":"Kun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenkun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengchao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizhi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2024.106723_bib0001","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12890-017-0498-z","article-title":"Effect of sivelestat sodium in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of randomized controlled trials","volume":"17","author":"Pu","year":"2017","journal-title":"BMC. Pulm. Med."},{"key":"10.1016\/j.ejps.2024.106723_bib0002","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ccm.2014.08.007","article-title":"Approach to the patient with the acute respiratory distress syndrome","volume":"35","author":"Janz","year":"2014","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.ejps.2024.106723_bib0003","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1378\/chest.07-2134","article-title":"Mortality rates for patients with acute lung injury\/ARDS have decreased over time","volume":"133","author":"Zambon","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ejps.2024.106723_bib0004","first-page":"2526","article-title":"Acute respiratory distress syndrome: the berlin definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMa"},{"key":"10.1016\/j.ejps.2024.106723_bib0005","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/cc6808","article-title":"Acute lung injury and the acute respiratory distress syndrome in Ireland: a prospective audit of epidemiology and management","volume":"12","year":"2008","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejps.2024.106723_bib0006","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0140-6736(03)12329-X","article-title":"Ventilator-associated lung injury","volume":"361","author":"Pinhu","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2024.106723_bib0007","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3389\/fchem.2020.00795","article-title":"Novel sulfonamide analogs of sivelestat as potent human neutrophil elastase inhibitors","volume":"8","author":"Crocetti","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejps.2024.106723_bib0008","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1510\/icvts.2009.225243","article-title":"Effect of a neutrophil elastase inhibitor on acute lung injury after cardiopulmonary bypass","volume":"10","author":"Fujii","year":"2010","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"10.1016\/j.ejps.2024.106723_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(02)02182-9","article-title":"The role of neutrophil elastase in acute lung injury","volume":"451","author":"Kawabata","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106723_bib0010","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.molimm.2010.04.020","article-title":"Serine proteases of the human immune system in health and disease","volume":"47","author":"Heutinck","year":"2010","journal-title":"Mol. Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.ejps.2024.106723_bib0011","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/15412555.2013.764403","article-title":"Neutrophil elastase-mediated lung disease","volume":"10","author":"Sandhaus","year":"2013","journal-title":"COPD"},{"key":"10.1016\/j.ejps.2024.106723_bib0012","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.23.021704.115653","article-title":"How neutrophils kill microbes","volume":"23","author":"Segal","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejps.2024.106723_bib0013","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3389\/fimmu.2019.01037","article-title":"Role of neutrophil extracellular traps and vesicles in regulating vascular endothelial permeability","volume":"10","author":"Ma","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2024.106723_bib0014","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/DDDT.S42004","article-title":"Usefulness of a selective neutrophil elastase inhibitor, sivelestat, in acute lung injury patients with sepsis","volume":"7","author":"Miyoshi","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ejps.2024.106723_bib0015","doi-asserted-by":"crossref","first-page":"11910","DOI":"10.21037\/apm-21-3164","article-title":"Efficacy, safety, and pharmacoeconomics of sivelestat sodium in the treatment of septic acute respiratory distress syndrome: a retrospective cohort study","volume":"10","author":"Gao","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.ejps.2024.106723_bib0016","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.pupt.2011.03.001","article-title":"Reevaluation of the efficacy and safety of the neutrophil elastase inhibitor, Sivelestat, for the treatment of acute lung injury associated with systemic inflammatory response syndrome; a phase IV study","volume":"24","author":"Aikawa","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2024.106723_bib0017","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0006-291X(91)91862-7","article-title":"ONO-5046, a novel inhibitor of human neutrophil elastase","volume":"177","author":"Kawabata","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2024.106723_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113876","article-title":"Detection of sivelestat and its metabolite in small volumes of plasma from Chinese ALI\/ARDS patients with SIRS via high-throughput UPLC-MS\/MS: a pharmacokinetic study","volume":"195","author":"Liu","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"Suppl 3","key":"10.1016\/j.ejps.2024.106723_bib0019","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2131\/jts.23.SupplementIII_483","article-title":"Toxicity study of sodium N-[2-[4-(2,2-dimethylpropionyloxy) phenylsulfonylamino] benzoyl] aminoacetate tetrahydrate (ONO-5046.Na) (5). 6-month repeated dose intravenous toxicity study in dogs with 1-month recovery test","volume":"23","author":"Okamoto","year":"1998","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.ejps.2024.106723_bib0020","unstructured":"Food and Drug Administration, 2021. Guidance for industry-estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. food and drug administration. https:\/\/www.fda.gov\/media\/72309\/download. Accessed 25 January 2022."},{"key":"10.1016\/j.ejps.2024.106723_bib0021","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/pst.326","article-title":"Exploratory assessment of dose proportionality: review of current approaches and proposal for a practical criterion","volume":"8","author":"Hummel","year":"2009","journal-title":"Pharm. Stat."},{"key":"10.1016\/j.ejps.2024.106723_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106437","article-title":"Safety, pharmacokinetics and exploratory exposure-response analysis of CX3002, a novel inhibitor of Xa, in Chinese healthy subjects","volume":"185","author":"Chen","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2024.106723_bib0023","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2174\/13892002113149990002","article-title":"Systematic evaluation of dose accumulation studies in clinical pharmacokinetics","volume":"14","author":"Li","year":"2013","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejps.2024.106723_bib0024","first-page":"10","article-title":"A comparison between single and double-pump syringe changes of intravenous inotropic medications in children","volume":"15","author":"Powell","year":"2004","journal-title":"Dynamics"},{"key":"10.1016\/j.ejps.2024.106723_bib0025","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/jch.13304","article-title":"Blood pressure variability: clinical relevance and application","volume":"20","author":"Parati","year":"2018","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.ejps.2024.106723_bib0026","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1161\/01.ATV.0000158311.24443.af","article-title":"Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis","volume":"25","author":"Laufs","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejps.2024.106723_bib0027","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1248\/bpb.20.392","article-title":"First-pass metabolism of ONO-5046 (N-[2-[4-(2,2-dimethylpropionyloxy)phenylsulfonylamino]benzoyl]aminoacetic acid), a novel elastase inhibitor, in rats","volume":"20","author":"Watanabe","year":"1997","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejps.2024.106723_bib0028","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1016\/j.bmcl.2015.08.049","article-title":"Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases: into clinical testing with pre-adaptive pharmacophores","volume":"25","author":"von Nussbaum","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2024.106723_bib0029","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1378\/chest.08-0422","article-title":"Advances in neutrophil biology: clinical implications","volume":"134","author":"Cowburn","year":"2008","journal-title":"Chest"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724000344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724000344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:09:46Z","timestamp":1760530186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724000344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":29,"alternative-id":["S0928098724000344"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106723","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, tolerability, pharmacokinetics and neutrophil elastase inhibitory effects of Sivelestat: A randomized, double-blind, placebo-controlled single- and multiple-dose escalation study in Chinese healthy subjects","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106723"}}